Learning outcomes
By the end of this lesson you should be able to: describe the three phases of haemostasis — vascular, platelet and coagulation — in order; list the vitamin K dependent clotting factors and name the drug that blocks their production; state which factors belong to the intrinsic, extrinsic and common pathways; interpret the prothrombin time and the activated partial thromboplastin time and say which drug each monitors; explain why the coagulation cascade is an example of positive feedback and why it is not a runaway process; and name the two anticoagulant systems that keep a clot local.
Prerequisites
Lessons 1 and 2. You need negative and positive feedback from Lesson 1, and membrane structure and transport from Lesson 2 for the phospholipid surface on which the cascade assembles.
The big idea
One idea holds the whole lesson together: the system exists to plug a hole, and a plug is by definition local. Every step is confined to the wound — by the properties of the damaged surface, by the need for a surface for the reactions to occur on, and by the action of inhibitors in the flowing blood around it. Haemostasis is therefore far more a problem of spatial restriction than of speed, and every bleeding disorder is either a failure to seal or a failure to keep the seal local.
The three phases
| Phase | Timescale | What happens | Clinical test |
|---|---|---|---|
| Vascular | Immediate | Endothelial damage exposes subendothelial collagen; the vessel constricts reflexly and locally | Not measured directly |
| Platelet | Seconds | Platelets adhere to the exposed collagen through von Willebrand factor, become activated, and aggregate to form a plug | The bleeding time, or now the platelet function assay |
| Coagulation | Minutes | The cascade generates thrombin, which converts fibrinogen to fibrin to stabilise the platelet plug | Prothrombin time and activated partial thromboplastin time |
NoteThe two halves of the plug are complementary and both are needed. Platelets are the bricks and fibrin is the mortar, which is why aspirin and clopidogrel give a mucosal pattern of bleeding — gums, nose, gut — while a coagulation factor failure such as haemophilia gives deep bleeding into joints and muscles.
The cascade
The classical diagram of the cascade is an oversimplification, and you need both the classical version, because that is what examinations use, and the cell-based version, because that is what is true. In the classical view, two pathways converge on a common pathway.
| Pathway | Trigger | Factors in sequence | Function |
|---|---|---|---|
| Intrinsic | Contact with a negatively charged surface such as collagen | XII, then XI, then IX acting with its cofactor VIII, converging on X | The amplification arm, and the one measured by the APTT |
| Extrinsic | Tissue factor released from damaged tissue | Tissue factor (factor III) binding factor VII, converging on X | The initiator arm, and the one measured by the PT |
| Common | Activated factor X | X with factor V, converting prothrombin (II) to thrombin, which converts fibrinogen (I) to fibrin | The shared final sequence |
The modern cell-based model makes one important correction to this scheme. Tissue factor and factor VII are not merely the initiating step — they do the bulk of the work. The contact factors (XII, and high-molecular-weight kininogen and prekallikrein) turn out to matter little for stopping bleeding: people deficient in factor XII have a hugely prolonged clotting time and do not bleed at all. That is a fact worth remembering, because it tells you how little the classical cascade has to do with real haemostasis.
A patient has a normal prothrombin time and a prolonged activated partial thromboplastin time. Which part of the cascade is likely deficient?
The vitamin K dependent factors
The warfarin sensitivity of this group is the reason the drug works. Warfarin blocks the enzyme that recycles vitamin K to its reduced form, so newly synthesised factors II, VII, IX and X cannot be carboxylated and cannot function. But note carefully which factor runs out first: factor VII has by far the shortest half-life, about six hours, and the prothrombin time — which is very sensitive to factor VII — is the first to lengthen. The antithrombotic effect takes days to build, because factor II (prothrombin) has a half-life of about three days.
| Factor | Half-life | Consequence for therapy |
|---|---|---|
| Factor VII | About six hours | The first to disappear, which is why the PT lengthens first |
| Factor IX | About 24 hours | Of intermediate importance in the initial response |
| Factor X | About 36 hours | Of intermediate importance in the initial response |
| Prothrombin (factor II) | About three days | The last to fall, and the source of the true anticoagulant effect |
| Protein C | About eight hours | Falls early, so warfarin's early procoagulant state and the skin necrosis of protein C deficiency |
Watch outWarfarin's earliest effect is paradoxically prothrombotic, because protein C — a natural anticoagulant — falls before the procoagulant factors do. This is the basis of warfarin-induced skin necrosis in protein C deficiency, and the reason a patient with an acute clot is started on heparin until the warfarin effect is established.
Worked example: the tests
Two clotting tests cover almost everything that goes wrong, and their names tell you what they measure.
| Test | What is added | Pathway measured | Used to monitor | Typical reference |
|---|---|---|---|---|
| Prothrombin time (PT) | Tissue factor and calcium, which drives the extrinsic pathway | Factors VII, X, V, II and I | Warfarin, reported as the INR | About 11 to 13.5 seconds, or INR 1 |
| Activated partial thromboplastin time (APTT) | A contact activator plus calcium, which drives the intrinsic pathway | Factors XII, XI, IX and VIII, then the common pathway | Unfractionated heparin | About 30 to 40 seconds |
| Thrombin time | Thrombin, which converts fibrinogen directly | Fibrinogen and the presence of inhibitors | Direct thrombin inhibitors; fibrinogen deficiency | About 15 to 20 seconds |
The international normalised ratio exists because the prothrombin time depends entirely on which thromboplastin reagent the laboratory uses. The INR is a mathematical correction: it multiplies the patient's PT ratio by the international sensitivity index of the reagent, so that a value means the same thing in every hospital. The therapeutic target for most anticoagulation is an INR of about 2 to 3.
NoteLow molecular weight heparin does not need the APTT, because it mostly potentiates factor Xa rather than thrombin and cannot be measured by a clotting test: it is monitored by anti-Xa activity, and usually only by anti-Xa activity in renal impairment or pregnancy.
Common mistakes
Watch outSaying factor VI exists. There is no factor VI: the numbering was left with a gap after a factor was renumbered. The assigned factors run I, II, III, IV, V, VII, VIII, IX, X, XI, XII and XIII, plus the unassigned four functional proteins of the anticoagulant and contact systems.
Watch outSaying heparin is monitored by the PT. Unfractionated heparin is monitored by the APTT; warfarin is monitored by the PT and reported as the INR. Reversing the two is a classic examination slip and a real-world medication error.
Watch outCalling the clotting cascade negative feedback. Thrombin activates more thrombin generation, so it is positive feedback — and it terminates only because the trigger is covered, the activated factors are diluted in flowing blood, and anticoagulant pathways oppose them.
Check your understanding
Give the classical three arms of the coagulation cascade with their factors.
A patient on warfarin has an INR of 2.6. Which factors are suppressed, and which is the last to fall?
Why does a haemophiliac bleed into joints rather than into the gums?
Multiple choice
Which set of factors is vitamin K dependent?
Which test best monitors warfarin therapy?
A patient has a prolonged activated partial thromboplastin time with a normal prothrombin time and a normal thrombin time. Which deficiency is most likely?
Which statement about the von Willebrand factor is correct?
Which statement about heparin is correct?
Which statement about platelets and clotting is correct?
Summary and next
Haemostasis runs in three phases — vascular constriction, a platelet plug bridged by von Willebrand factor, and a coagulation cascade that converts soluble fibrinogen into insoluble fibrin. The classical arms are intrinsic (XII, XI, IX with VIII), extrinsic (tissue factor with VII) and common (X with V, prothrombin to thrombin to fibrin), and the vitamin K dependent factors II, VII, IX and X are what warfarin blocks. The prothrombin time and its INR monitor warfarin; the activated partial thromboplastin time monitors heparin; and the cascade is positive feedback that is confined to the wound by dilution, by the need for a surface, and by the anticoagulant pathways.
Next: the other defence carried by blood. You will meet the innate system that acts within minutes without regard for the identity of the invader, and the adaptive system that takes days but remembers the invader for life.